![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
CP France, JM Moerschbaecher and JH Woods
Department of Pharmacology, University of Michigan, Ann Arbor.
MK-801 [(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5, 10- imine maleate] and related compounds were studied in monkeys discriminating between 0.032 mg/kg of (+)-MK-801 and saline and in a separate group of monkeys responding under a multiple schedule of repeated acquisition and performance of conditional discriminations. In the drug discrimination study, small doses of (+)-MK-801 occasioned saline-lever responding whereas larger doses occasioned responding on the MK-801 lever. Dexoxadrol substituted completely (greater than or equal to 90%) for the MK-801 discriminative stimulus in all subjects whereas dextrorphan and phencyclidine (PCP) substituted in only two of three subjects. Neither ketamine, (+)-N-allylnormetazocine, dextromethorphan nor the competitive excitatory amino acid antagonist CGS 19755 [cis-4-phosphonomethyl-2-piperidine-carboxylic acid] substituted for MK-801 in any of the monkeys. PCP, dextrorphan, dextromethorphan, (+)- and (-)-MK-801 decreased rates of lever pressing and increased errors in both components of the multiple acquisition, performance schedule. For each compound errors were increased in the acquisition component with doses smaller than doses required to increase errors in the performance component. In both procedures (+)-MK- 801 was 10 times more potent than (-)-MK-801, although qualitatively similar results were obtained with the two enantiomers. PCP-like drugs have many effects in common, including their effects on learning and performance; however, with regard to discriminative stimulus effects this does not appear to be a homogenous pharmacological class, suggesting that change in excitatory amino acid-mediated neurotransmission might not be the only mechanism by which MK-801 and related compounds exert behavioral effects in nonhuman primates.
This article has been cited by other articles:
|
|
 |
|
  S. M. Dravid, K. Erreger, H. Yuan, K. Nicholson, P. Le, P. Lyuboslavsky, A. Almonte, E. Murray, C. Mosley, J. Barber, et al. Subunit-specific mechanisms and proton sensitivity of NMDA receptor channel block J. Physiol., May 15, 2007; 581(1): 107 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. M. Campbell, E. R. Butelman, and J. H. Woods Effects of (+)-HA-966, CGS-19755, Phencyclidine, and Dizocilpine on Repeated Acquisition of Response Chains in Pigeons: Systemic Manipulation of Central Glycine Sites J. Pharmacol. Exp. Ther., April 1, 1999; 289(1): 521 - 527. [Abstract] [Full Text]
|
|
|
|
 |
|
 J. H. Krystal, I. L. Petrakis, E. Webb, N. L. Cooney, L. P. Karper, S. Namanworth, P. Stetson, L. A. Trevisan, and D. S. Charney Dose-Related Ethanol-like Effects of the NMDA Antagonist, Ketamine, in Recently Detoxified Alcoholics Arch Gen Psychiatry, April 1, 1998; 55(4): 354 - 360. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. M. Witkin, T. D. Steele, and L. G. Sharpe Effects of Strychnine-Insensitive Glycine Receptor Ligands in Rats Discriminating Dizocilpine or Phencyclidine from Saline J. Pharmacol. Exp. Ther., January 1, 1997; 280(1): 46 - 52. [Abstract] [Full Text]
|
|
 |
 |
 |
|
 |
 |
 |
